Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency

Cytotherapy

Volumn 13, Issue 6, 2011, Pages 661-674

  Ren, Jiaqiang ^a   Jin, Ping ^a   Sabatino, Marianna ^a   Balakumaran, Arun ^b   Feng, Ji ^a   Kuznetsov, Sergei A ^b   Klein, Harvey G ^a   Robey, Pamela G ^b   Stroncek, David F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

bone marrow stromal cells; extracellular proteins; global transcriptome analysis; potency

Indexed keywords

ACTIN; ALPHA5 INTEGRIN; BETA5 INTEGRIN; BIOLOGICAL MARKER; CATENIN; CD34 ANTIGEN; CLATHRIN; COLLAGEN TYPE 3; COLLAGEN TYPE 5; CONNECTIVE TISSUE GROWTH FACTOR; CYTOSKELETON PROTEIN; DISINTEGRIN; FIBRONECTIN; INTEGRIN; INTEGRIN LINKED KINASE; MACROPHAGE ELASTASE; OLIGONUCLEOTIDE; RHO FACTOR; SCLEROPROTEIN; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL INTERACTION; CELL LINE; CELL METABOLISM; CELL MOTILITY; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOCYTOSIS; FIBROBLAST; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; UPREGULATION;

EID: 79959265855     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.548379     Document Type: Article

References (48)

1. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008; 2:313-9. (Pubitemid 351467394)
2. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32:1005-11. (Pubitemid 32285175)
3. Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery. 2004;55:1185-93.
4. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932-7. (Pubitemid 34693661)
5. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30:215-22. (Pubitemid 35023593)
6. Meuleman N, Vanhaelen G, Tondreau T, Lewalle P, Kwan J, Bennani J, et al. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica. 2008;93:e11-3.
7. Mankani MH, Kuznetsov SA, Marshall GW, Robey PG. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A. 2008;14:1949-58.
8. Mankani MH, Kuznetsov SA, Shannon B, Nalla RK, Ritchie RO, Qin Y, et al. Canine cranial reconstruction using auto logous bone marrow stromal cells. Am J Pathol. 2006;168:542-50. (Pubitemid 43271152)
9. Mankani MH, Kuznetsov SA, Wolfe RM, Marshall GW, Robey PG. In vivo bone formation by human bone marrow stromal cells: reconstruction of the mouse calvarium and mandible. Stem Cells. 2006;24:2140-9.
10. Kuznetsov SA, Huang KE, Marshall GW, Robey PG, Mankani MH. Long-term stable canine mandibular augmentation using autologous bone marrow stromal cells and hydroxyapatite/ tricalcium phosphate. Biomaterials. 2008;29:4211-6.
11. Phinney DG, Prockop DJ. Concise review. Mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair, current views. Stem Cells. 2007;25:2896-902.
12. Zhou Y, Wang S, Yu Z, Hoyt RF Jr, Sachdev V, Vincent P, et al. Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun. 2009;390:902-7.
13. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076-84. (Pubitemid 44128350)
14. Sadan O, Melamed E, Offen D. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases. Expert Opin Biol Ther. 2009;9:1487-97.
15. Le BK, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:321-34.
16. Horwitz EM, Dominici M. How do mesenchymal stromal cells exert their therapeutic benefit? Cytotherapy. 2008;10:771-4.
17. Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM, et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110:2764-7. (Pubitemid 47523204)
18. Le BK, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579-86. (Pubitemid 351626841)
19. Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl. 2010;16:118-29.
20. Le BK, Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med. 2007;262:509-25.
21. Pistoia V, Raffaghello L. Potential of mesenchymal stem cells for the therapy of autoimmune diseases. Expert Rev Clin Immunol. 2010;6:211-8.
22. Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, et al. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler. 2010;16:503-10.
23. Li Y, Chopp M. Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci Lett. 2009;456:120-3.
24. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11:377-91.
25. van den Berk LC, Figdor CG, Torensma R. Mesenchymal stromal cells: tissue engineers and immune response modulators. Arch Immunol Ther Exp (Warsz). 2008;56:325-9.
26. Ren J, Jin P, Wang E, Marincola FM, Stroncek DF. Micro-RNA and gene expression patterns in the differentiation of human embryonic stem cells. J Transl Med. 2009;7:20.
27. Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, et al. Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res. 2002;62:3581-6. (Pubitemid 34728828)
28. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-8. (Pubitemid 29003722)
29. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:3.
30. Goessler UR, Bugert P, Bieback K, Stern-Straeter J, Bran G, Sadick H, et al. In vitro-analysis of integrin-expression in stem-cells from bone marrow and cord blood during chondrogenic differentiation. J Cell Mol Med. 2009;13:1175-84.
31. Goessler UR, Bugert P, Bieback K, Stern-Straeter J, Bran G, Hormann K, et al. Integrin expression in stem cells from bone marrow and adipose tissue during chondrogenic differentiation. Int J Mol Med. 2008;21:271-9. (Pubitemid 351336881)
32. Lal H, Verma SK, Foster DM, Golden HB, Reneau JC, Watson LE, et al. Integrins and proximal signaling mechanisms in cardiovascular disease. Front Biosci. 2009;14:2307-34.
33. Jaganathan BG, Ruester B, Dressel L, Stein S, Grez M, Seifried E, et al. Rho inhibition induces migration of mesenchymal stromal cells. Stem Cells. 2007;25:1966-74. (Pubitemid 47258174)
34. Markov V, Kusumi K, Tadesse MG, William DA, Hall DM, Lounev V, et al. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev. 2007;16:53-73. (Pubitemid 46362592)
35. Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, et al. Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells. 2005;23:584-93. (Pubitemid 40478497)
36. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857-902.
37. Magnon C, Frenette PS. Hematopoietic stem cell trafficking. In: StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008; Jul 14.
38. Casey TM, Eneman J, Crocker A, White J, Tessitore J, Stanley M, et al. Cancer associated fibroblasts stimulated by transforming growth factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a population study. Breast Cancer Res Treat. 2008;110:39-49. (Pubitemid 351793849)
39. Zhang Y, Wen G, Shao G, Wang C, Lin C, Fang H, et al. TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res. 2009;69:37-44.
40. Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM. Cellular roles of ADAM12 in health and disease. Int J Biochem Cell Biol. 2008;40:1685-702.
41. Fedak PW, Moravec CS, McCarthy PM, Altamentova SM, Wong AP, Skrtic M, et al. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation. 2006;113:238-45.
42. Cicha I, Goppelt-Struebe M. Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors. 2009;35:200-8.
43. Rachfal AW, Brigstock DR. Structural and functional properties of CCN proteins. Vitam Horm. 2005;70:69-103. (Pubitemid 43589023)
44. Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, Popova E, et al. Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS ONE. 2009;4:e6743.
45. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood. 2008;112:295-307.
46. Wagner EF. Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun). Ann Rheum Dis. 2010;69(Suppl 1):i86-8.
47. Wagner EF, Eferl R. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 2005;208:126-40. (Pubitemid 41746389)
48. Maehata Y, Takamizawa S, Ozawa S, Izukuri K, Kato Y, Sato S, et al. Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 2-phosphate, a long-acting vitamin C derivative. Matrix Biol. 2007;26: 371-81. (Pubitemid 46813224)